The two companies will seek to develop drugs, herbal medicines, nutritional supplements, functional foods, food ingredients, cosmetic ingredients, crop protection ingredients and other life sciences applications by exploring the rich resources of Malaysia.
IMD will contribute its world leading expertise and technology platform for the discovery of natural products in order to build a proprietary portfolio of potential products derived from naturally sourced materials. Biotropics will further develop these candidates into premium products for the world markets.
“We are delighted to have this new agreement with Biotropics, which is a significant step forward in our sustainable business growth through integrated research-based value generation, validating our strong research capabilities,” said Bernard Becker, managing director of InterMed Discovery. “It further opens business avenues and perspectives into one of the most biodiverse countries and economically most dynamic regions in the world.”
“Malaysia is one of the most biodiversity-rich countries in the world, and this resource has been accessed for thousands of years on a local basis” said Christof Jaenicke, CEO of Biotropics Malaysia Berhad. “With the help of InterMed Discovery we are positioned to commercialize this resource to the whole world while ensuring economic benefit for Malaysia in return.”